RxDoctor Payments Data

Johan Forslund, MD

Adult Reconstructive Orthopaedic Surgery · Fullerton, CANPI 1982138665

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 59.0% of the total. Reporting peaked in 2022 at $3,825 and has fallen 55.9% since, to $1,688 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in CA, where the typical reported total is $9,645.

$10,125in general payments, 2019–2025

Across 79 payments — averaging $128.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Stryker$2K
  • Zimmer Biomet$1K
  • Globus Medical$248
  • Medtronic$124
  • Medical Device Business Services, Inc.$54
  • plus $114 from 6 others

What the payments were for

  • Travel & lodging$2,68927%
  • Food & beverage$3,76537%
  • Education$3,67136%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,125 in reported general payments places this provider in the 50th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$172,394
Medicare patients
349
Services billed
5,234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$8,163
Celecoxib80$2,183
Oxycodone Hcl173$962
Cefadroxil114$595
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$339
Pregabalin18$270
Ondansetron OdtOndansetron30$253
Tramadol Hcl70$242
Methylprednisolone37$227
Dexamethasone102$182
Ondansetron Hcl48$167
Amoxicillin66$153
Gabapentin15$75
Meloxicam15$21

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Fullerton

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →